Vimarsana
Biggest News Aggregation in the World

Aml Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aml Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aml Therapy Today - Breaking & Trending Today

Quizartinib Becomes SOC Option in Newly Diagnosed AML With FLT3 ITD Mutation - Vimarsana News

Quizartinib Becomes SOC Option in Newly Diagnosed AML With FLT3 ITD Mutation

Quizartinib added to induction and consolidation chemotherapy and continued as a single agent for up to 36 cycles improves the overall survival of adults with FLT3 ITD mutated AML.